FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Gill

Research Profile

Chemicals & Drugs

Concepts & Ideas

Disorders

Procedures

Co-author Network

Publications

TOP 3
Stan Louie; David Alexander Sclar; Mark A Gill
Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.
Alfred Chin; Shanshan Liu; Jennifer Ting-Chan; Mark A Gill
Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection.
Mark A Gill; Alice Z Kislik; Lana Gore; Angela Chandna
Stability of advanced life support drugs in the field.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Gill (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Stan Louie; David Alexander Sclar; Mark A Gill
Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.
The Annals of pharmacotherapy 2005;39(11):1861-9.
2005: Alfred Chin; Shanshan Liu; Jennifer Ting-Chan; Mark A Gill
Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2005;62(10):1073-4.
2004: Mark A Gill; Alice Z Kislik; Lana Gore; Angela Chandna
Stability of advanced life support drugs in the field.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2004;61(6):597-602.
2004: Emily E Han; Paul M Beringer; Stan Louie; Mark A Gill; Bertrand Shapiro
Pharmacokinetics of Ibuprofen in children with cystic fibrosis.
Clinical pharmacokinetics 2004;43(3):145-56.
2004: Howard Belzberg; Jay Zhu; Edward E Cornwell; James A Murray; Jack Sava; Ali Salim; George C Velmahos; Mark A Gill
Imipenem levels are not predictable in the critically ill patient.
The Journal of trauma 2004;56(1):111-7.
2003: Bradley R Williams; Arlette Nazarians; Mark A Gill
A review of rivastigmine: a reversible cholinesterase inhibitor.
Clinical therapeutics 2003;25(6):1634-53.
2003: Pål F Sprauten; Paul M Beringer; Stan Louie; Timothy W Synold; Mark A Gill
Stability and antibacterial activity of cefepime during continuous infusion.
Antimicrobial agents and chemotherapy 2003;47(6):1991-4.
2002: Thao Nguyen; Stan Louie; Paul M Beringer; Mark A Gill
Potential role of macrolide antibiotics in the management of cystic fibrosis lung disease.
Current opinion in pulmonary medicine 2002;8(6):521-8.
2001: M J Montgomery; Paul M Beringer; Amir Aminimanizani; Stan Louie; Bertrand Shapiro; Roger W Jelliffe; Mark A Gill
Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
Antimicrobial agents and chemotherapy 2001;45(12):3468-73.
2000: M J Montgomery; Paul M Beringer; Stan Louie; Mark A Gill
Estimation of creatinine clearance in patients with metastatic ovarian cancer.
Therapeutic drug monitoring 2000;22(6):695-700.
2000: Stan Louie; Alfred Chin; Mark A Gill
Activity of dalteparin sodium in polypropylene syringes.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2000;57(8):760-2.
2000: B P Peters; F G Weissman; Mark A Gill
Pathophysiology and treatment of psoriasis.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2000;57(7):645-59; quiz 660-1.
1999: L J Nii; Alfred Chin; T M Cao; Mark A Gill
Stability of sumatriptan succinate in polypropylene syringes.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1999;56(10):983-5.
1997: Edward E Cornwell; Howard Belzberg; Thomas V Berne; Mark A Gill; Dimitrios Theodorou; J W Kern; W Yu; Juan Asensio; D Demetriades
Pharmacokinetics of aztreonam in critically ill surgical patients.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1997;54(5):537-40.
1997: Y S Moon; K C Chung; Mark A Gill
Pharmacokinetics of meropenem in animals, healthy volunteers, and patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24 Suppl 2():S249-55.
1997: Michael B Nichol; J E Margolies; Mark A Gill
Factors associated with antihypertensive prescribing.
The Annals of pharmacotherapy 1997;31(2):154-9.
1996: A Chin; Y S Moon; K C Chung; Mark A Gill
Stability of granisetron hydrochloride with dexamethasone sodium phosphate for 14 days.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1996;53(10):1174-6.
1996: Thomas V Berne; Albert E Yellin; M D Appleman; P N Heseltine; Mark A Gill
Meropenem versus tobramycin with clindamycin in the antibiotic management of patients with advanced appendicitis.
Journal of the American College of Surgeons 1996;182(5):403-7.
1995: T W Park; L P Le-Bui; K C Chung; J P Rho; Mark A Gill
Stability of piperacillin sodium-tazobactam sodium in peritoneal dialysis solutions.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1995;52(18):2022-4.
1995: K C Chung; Y S Moon; A Chin; R W Ulrich; Mark A Gill
Compatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administration.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1995;52(14):1554-6.
1995: K C Chung; A Chin; Mark A Gill
Stability of granisetron hydrochloride in a disposable elastomeric infusion device.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1995;52(14):1541-3.
1995: S S Jhee; J W Kern; J P Burm; Albert E Yellin; Mark A Gill
Piperacillin-tazobactam pharmacokinetics in patients with intraabdominal infections.
Pharmacotherapy 1995;15(4):472-8.
1995: Y S Moon; K C Chung; A Chin; Mark A Gill
Stability of piperacillin sodium-tazobactam sodium in polypropylene syringes and polyvinyl chloride minibags.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1995;52(9):999-1001.
1995: S S Jhee; Mark A Gill; Albert E Yellin; Thomas V Berne; P N Heseltine; M D Appleman
Pharmacoeconomics of piperacillin/tazobactam and imipenem/cilastatin in the treatment of patients with intra-abdominal infections.
Clinical therapeutics 1995;17(1):126-35.
1994: J P Burm; J S Choi; S S Jhee; A Chin; R W Ulrich; Mark A Gill
Stability of paclitaxel and fluconazole during simulated Y-site administration.
American journal of hospital pharmacy 1994;51(21):2704-6.
1994: J S Choi; J P Burm; S S Jhee; A Chin; R W Ulrich; Mark A Gill
Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration.
American journal of hospital pharmacy 1994;51(18):2273-6.
1994: S S Jhee; J P Burm; Mark A Gill
Comparison of aminoglycoside pharmacokinetics in Asian, Hispanic, and Caucasian patients by using population pharmacokinetic methods.
Antimicrobial agents and chemotherapy 1994;38(9):2073-7.
1994: J P Burm; S S Jhee; A Chin; Y S Moon; E Jeong; L Nii; J L Fox; Mark A Gill
Stability of paclitaxel with ondansetron hydrochloride or ranitidine hydrochloride during simulated Y-site administration.
American journal of hospital pharmacy 1994;51(9):1201-4.
1994: M P Okamoto; R K Nakahiro; A Chin; A Bedikian; Mark A Gill
Cefepime: a new fourth-generation cephalosporin.
American journal of hospital pharmacy 1994;51(4):463-77; quiz 541-2.
1994: F M Pompilio; J L Fox; K Inagaki; J P Burm; S Jhee; Mark A Gill
Stability of ranitidine hydrochloride with ondansetron hydrochloride or fluconazole during simulated Y-site administration.
American journal of hospital pharmacy 1994;51(3):391-4.
1994: A Bedikian; M P Okamoto; R K Nakahiro; J Farino; P N Heseltine; M D Appleman; Albert E Yellin; Thomas V Berne; Mark A Gill
Pharmacokinetics of meropenem in patients with intra-abdominal infections.
Antimicrobial agents and chemotherapy 1994;38(1):151-4.
1993: David A Sclar; Tracy L Skaer; Linda M Robison; A Chin; M P Okamoto; R K Nakahiro; Mark A Gill
Effect of antihypertensive formulation on health service expenditures.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1993;3(6):363-8.
1993: S S Jhee; E W Jeong; A Chin; K Inagaki; J L Fox; Mark A Gill
Stability of ondansetron hydrochloride stored in a disposable, elastomeric infusion device at 4 degrees C.
American journal of hospital pharmacy 1993;50(9):1918-20.
1993: Tracy L Skaer; David A Sclar; Linda M Robison; A Chin; Mark A Gill; M P Okamoto; R K Nakahiro
Effect of pharmaceutical formulation for antihypertensive therapy on health service utilization.
Clinical therapeutics 1993;15(4):715-25; discussion 714.
1993: K Inagaki; J Takagi; E Lor; K J Lee; L Nii; Mark A Gill
Stability of fluconazole in commonly used intravenous antibiotic solutions.
American journal of hospital pharmacy 1993;50(6):1206-8.
1993: A Bedikian; Mark A Gill
Impact of triplicate prescribing programme on psychotropic prescribing.
PharmacoEconomics 1993;3(2):172-3.
1993: M P Okamoto; Mark A Gill; R K Nakahiro; A Bedikian; A Chin; Albert E Yellin; Thomas V Berne; C A Knupp
Cefepime pharmacokinetics in patients with acute cholecystitis undergoing cholecystectomy.
Clinical pharmacy 1993;12(2):134-7.
1993: K Inagaki; Mark A Gill; M P Okamoto; J Takagi
Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
Journal of parenteral science and technology : a publication of the Parenteral Drug Association 1993;47(1):35-9.
1993: Albert E Yellin; Thomas V Berne; M D Appleman; P N Heseltine; Mark A Gill; M P Okamoto; F J Baker; C Holcomb
A randomized study of cefepime versus the combination of gentamicin and mezlocillin as an adjunct to surgical treatment in patients with acute cholecystitis.
Surgery, gynecology & obstetrics 1993;177 Suppl():23-9; discussion 35-40.
1993: Thomas V Berne; Albert E Yellin; M D Appleman; P N Heseltine; Mark A Gill
A clinical comparison of cefepime and metronidazole versus gentamicin and clindamycin in the antibiotic management of surgically treated advanced appendicitis.
Surgery, gynecology & obstetrics 1993;177 Suppl():18-22; discussion 35-40.
1992: K Inagaki; Mark A Gill; M P Okamoto; J Takagi
Stability of ranitidine hydrochloride with aztreonam, ceftazidime, or piperacillin sodium during simulated Y-site administration.
American journal of hospital pharmacy 1992;49(11):2769-72.
1992: K Inagaki; J Takagi; E Lor; M P Okamoto; Mark A Gill
Determination of fluconazole in human serum by solid-phase extraction and reversed-phase high-performance liquid chromatography.
Therapeutic drug monitoring 1992;14(4):306-11.
1992: M P Okamoto; Mark A Gill; R K Nakahiro; A Chin; Albert E Yellin; Thomas V Berne; David A Sclar; C A Knupp; P N Heseltine; M D Appleman
Tissue concentrations of cefepime in acute cholecystitis patients.
Therapeutic drug monitoring 1992;14(3):220-5.
1992: Mark A Gill; M P Okamoto; R K Nakahiro; A Chin; K Inagaki; David A Sclar
Pharmacokinetic population parameters for aminoglycosides in cholecystitis patients.
Therapeutic drug monitoring 1992;14(2):107-11.
1991: R K Nakahiro; M P Okamoto; A Chin; Mark A Gill; J S Chae; David A Sclar
Use of gentamicin clearance in estimating renal function.
Clinical pharmacy 1991;10(12):931-4.
1991: David A Sclar; Tracy L Skaer; A Chin; M P Okamoto; Mark A Gill
Utility of a transdermal delivery system for antihypertensive therapy. Part 2.
The American journal of medicine 1991;91(1A):57S-60S.
1991: David A Sclar; Tracy L Skaer; A Chin; M P Okamoto; Mark A Gill
Utility of a transdermal delivery system for antihypertensive therapy. Part 1.
The American journal of medicine 1991;91(1A):50S-56S.
1991: David A Sclar; A Chin; Tracy L Skaer; M P Okamoto; R K Nakahiro; Mark A Gill
Effect of health education in promoting prescription refill compliance among patients with hypertension.
Clinical therapeutics 1991;13(4):489-95.
1991: David A Sclar; Tracy L Skaer; A Chin; M P Okamoto; R K Nakahiro; Mark A Gill
Effectiveness of the C Cap in promoting prescription refill compliance among patients with glaucoma.
Clinical therapeutics 1991;13(3):396-400.
1991: Albert E Yellin; P N Heseltine; Thomas V Berne; M D Appleman; Mark A Gill; F C Chenella
Intramuscular imipenem as adjuvant therapy for acute cholecystitis and perforated or gangrenous appendicitis.
Chemotherapy 1991;37 Suppl 2():37-43.
1991: M P Okamoto; A Chin; Mark A Gill; Albert E Yellin; Thomas V Berne; P N Heseltine; M D Appleman; C A Knupp; David A Sclar
Analysis of cefepime tissue penetration into human appendix.
Pharmacotherapy 1991;11(5):353-8.
1990: A Chin; M P Okamoto; Mark A Gill; David A Sclar; Thomas V Berne; Albert E Yellin; P N Heseltine; M D Appleman
Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue.
Antimicrobial agents and chemotherapy 1990;34(12):2354-7.
1990: M P Okamoto; A Chin; Mark A Gill; Albert E Yellin; Thomas V Berne; P N Heseltine; M D Appleman
Comparison of two microcomputer Bayesian pharmacokinetic programs for predicting serum gentamicin concentrations.
Clinical pharmacy 1990;9(9):708-11.
1990: A Chin; Mark A Gill; Matthew Ito; Albert E Yellin; Thomas V Berne; P N Heseltine; M D Appleman
Treatment of intra-abdominal infections: cost comparison of ampicillin/sulbactam and clindamycin/gentamicin.
Hospital formulary 1990;25(3):295-6, 303-5.
1990: Thomas V Berne; Albert E Yellin; M D Appleman; Mark A Gill; F C Chenella; P N Heseltine
Controlled comparison of cefmetazole with cefoxitin for prophylaxis in elective cholecystectomy.
Surgery, gynecology & obstetrics 1990;170(2):137-40.
1989: A Chin; Mark A Gill; Matthew Ito; Albert E Yellin; Thomas V Berne; P N Heseltine; M D Appleman
Cost analysis of two clindamycin dosing regimens.
DICP : the annals of pharmacotherapy 1989;23(12):980-3.
1989: A Chin; Mark A Gill; Matthew Ito; A E Yellin; T V Berne; P N Heseltine; M D Appleman
A cost comparison of intramuscular versus intravenous imipenem.
Hospital pharmacy 1989;24(11):905-9.
1989: A Chin; Mark A Gill; Matthew Ito; Albert E Yellin; Thomas V Berne; P N Heseltine; M D Appleman; F C Chenella
Evaluation of two different dosage regimens of clindamycin and the penetration into human appendix.
Therapeutic drug monitoring 1989;11(4):421-4.
1988: Matthew Ito; Mark A Gill; F C Chenella; Thomas V Berne; Albert E Yellin; P N Heseltine; M D Appleman
Intraoperative serum, bile, and gallbladder-wall concentrations of cefmetazole in patients undergoing cholecystectomy.
Clinical pharmacy 1988;7(6):467-8.
1988: J K Noguchi; Mark A Gill
Sulbactam: a beta-lactamase inhibitor.
Clinical pharmacy 1988;7(1):37-51.
1987: A K Hurst; K T Iseri; Mark A Gill; J K Noguchi; T M Gilman; Roger W Jelliffe
Comparison of four methods for predicting serum gentamicin concentrations in surgical patients with perforated or gangrenous appendicitis.
Clinical pharmacy 1987;6(3):234-8.
1987: Thomas V Berne; Albert E Yellin; M D Appleman; Mark A Gill; F C Chenella; P N Heseltine
Surgically treated gangrenous or perforated appendicitis. A comparison of aztreonam and clindamycin versus gentamicin and clindamycin.
Annals of surgery 1987;205(2):133-7.
1986: F C Chenella; T A Klotz; Mark A Gill; Y J Paulson; J K Noguchi; A K Hurst; D C Robinson; K Hill-Besinque; C M Clifford; W G McGehee
Blood-sampling strategy for monitoring continuous intravenous heparin therapy.
Clinical pharmacy 1986;5(6):510-3.
1986: P N Heseltine; T V Berne; A E Yellin; Mark A Gill; M D Appleman
The efficacy of cefoxitin vs. clindamycin/gentamicin in surgically treated stab wounds of the bowel.
The Journal of trauma 1986;26(3):241-5.
1986: Mark A Gill; F C Chenella; P N Heseltine; M D Appleman; Albert E Yellin; Thomas V Berne; M J Feldman; D Sharon
Cost analysis of antibiotics in the management of perforated or gangrenous appendicitis.
American journal of surgery 1986;151(2):200-4.
1986: Mark A Gill; T C Cheetham; F C Chenella; P N Heseltine; Albert E Yellin; M D Appleman; Thomas V Berne
Matched case-control study of adjusted versus nonadjusted gentamicin dosing in perforated and gangrenous appendicitis.
Therapeutic drug monitoring 1986;8(4):451-6.
1986: P N Heseltine; Albert E Yellin; M D Appleman; Mark A Gill; F C Chenella; Thomas V Berne; John Leedom
Imipenem therapy for perforated and gangrenous appendicitis.
Surgery, gynecology & obstetrics 1986;162(1):43-8.
1985: Albert E Yellin; P N Heseltine; Thomas V Berne; M D Appleman; Mark A Gill; C E Riggio; F C Chenella
The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis.
Surgery, gynecology & obstetrics 1985;161(4):303-7.
1984: Mark A Gill; J L Cohen; F C Chenella; G H Hisayasu; P Chandrasoma; G M Warnecke; H Chung; P N Heseltine; Albert E Yellin; Thomas V Berne
Gentamicin penetration into diseased appendix tissue.
Therapeutic drug monitoring 1984;6(3):298-301.
1984: Mark A Gill; J W Kern; F C Chenella; P N Heseltine; Albert E Yellin; G Foulds; Thomas V Berne
Pharmacokinetics of parenteral sulbactam in patients with appendicitis.
Therapeutic drug monitoring 1984;6(4):428-31.
1983: F C Chenella; T A Klotz; Mark A Gill; J W Kern; W F McGhan; Y J Paulson; K M Schuttenhelm; T C Cheetham; J K Noguchi; W G McGehee
Comparison of physician and pharmacist management of anticoagulant therapy of inpatients.
American journal of hospital pharmacy 1983;40(10):1642-5.
1983: P N Heseltine; Albert E Yellin; M D Appleman; Mark A Gill; F C Chenella; J W Kern; Thomas V Berne
Perforated and gangrenous appendicitis: an analysis of antibiotic failures.
The Journal of infectious diseases 1983;148(2):322-9.
1983: M J Torres; J W Kern; Mark A Gill; Thomas V Berne; P N Heseltine; Albert E Yellin; F C Chenella
Comparison of serum sampling methods for estimating gentamicin pharmacokinetic variables.
Clinical pharmacy 1983;2(4):353-5.
1983: Mark A Gill; J W Kern; F C Chenella; Thomas V Berne; P N Heseltine; Albert E Yellin
Influence of manufacturer lot number on pharmacokinetic manipulation of gentamicin serum concentrations.
Therapeutic drug monitoring 1983;5(4):419-22.